Global Blood Typing Market Size To Exceed USD 4.52 Billion By 2033: Market Statistics Report

RELEASE DATE: Jun 2025 Author: Spherical Insights
The Global Blood Typing Market Size is Expected to Grow from USD 1.94 Billion in 2023 to USD 4.52 Billion by 2033, at a CAGR of 8.83% during the forecast period 2023-2033

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis


Related Topics

Palmitic Acid Market Size Herbal Extract Market Size Furandicarboxylic Acid Market Size Automotive Webbing Market Size

Global Blood Typing Market Size To Exceed USD 4.52 Billion By 2033

According to a research report published by Spherical Insights & Consulting, The Global Blood Typing Market Size is Expected to Grow from USD 1.94 Billion in 2023 to USD 4.52 Billion by 2033, at a CAGR of 8.83% during the forecast period 2023-2033.

 

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Blood Typing Market Size, Share, and COVID-19 Impact Analysis, By Product & Services (Instruments and Reagents & Consumables), By Test (Antibody Screening, HLA Typing, and Cross-matching), By End User (Hospitals & clinics, Diagnostic laboratories, and Blood banks), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

 

The global blood typing market refers to the industry involved in the creation, manufacturing, and marketing of medical devices or gadgets, and services used for determining an individual's blood type. A vital medical procedure termed blood typing determines a person's specific blood group (such as A, B, AB, or O and Rh factor), which is required for organ transplants, safe blood transfusions, prenatal care, and disease diagnosis. Key driving factors for the growth of the blood typing market include the growing number of chronic disease cases, more operations, and an increase in the need for safe blood transfusions. Additional factors driving growth in the market include growing healthcare infrastructure, especially among developing countries, rising awareness of transfusion safety, and technological advances. Initiatives from the government additionally promote blood testing and donation, which are likely to contribute to market growth. However, high expenses of advanced diagnostic tools, an absence of competent doctors, restricted access to medical facilities in remote locations, and a lack of awareness of the significance of precise blood type identification.

 

The reagents & consumables segment accounted for the largest revenue share in 2023 and is projected to grow at a significant CAGR during the forecast period.

On the basis of product & services, the global blood typing market is divided into instruments and reagents & consumables. Among these, the reagents & consumables segment accounted for the largest revenue share in 2023 and is projected to grow at a significant CAGR during the forecast period. The segment growth is attributed to the high frequency of testing, continuous demand, growing healthcare facilities, rising blood donation rates, and continual developments that improve blood typing techniques' accuracy and efficiency. 

 

The antibody screening segment accounted for the highest revenue share in 2023 and is anticipated to grow at a substantial CAGR during the forecast period.

On the basis of the test, the global blood typing market is divided into antibody screening, HLA typing, and cross-matching. Among these, the antibody screening segment accounted for the highest revenue share in 2023 and is anticipated to grow at a substantial CAGR during the forecast period. The segment growth can be attributed to increased demand for blood products and antibody screening due to increased prenatal testing, increased transfusion volumes, rising prevalence of chronic illnesses, and improvements in genetic and diagnostic testing.

 

The diagnostic laboratories segment accounted for the largest market share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.

On the basis of end user, the global blood typing market is divided into hospitals & clinics, diagnostic laboratories, and blood banks. Among these, the diagnostic laboratories segment accounted for the largest market share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment growth is driven by the increasing demand for accurate diagnoses in transplants of organs and blood transfusions, continual evaluation of technology developments, developed access to healthcare, and additional government efforts to upgrade medical infrastructure across the globe.

 

North America is anticipated to hold the largest share of the global blood typing market over the predicted timeframe.

North America is anticipated to hold the largest share of the global blood typing market over the predicted timeframe. The regional market growth can be attributed to an effective blood bank network, numerous blood drives, significant medical expenses, and an aging population that needs transfusions regularly. The region's emphasis on early disease identification and tailored medication additionally increases market demand.

 

Asia Pacific is expected to grow at the fastest CAGR in the global blood typing market during the forecast period. The segment growth is driven because of an increase in blood donation campaigns, a rise in transfusions connected to trauma and surgery, a rise in demand for prenatal and postnatal testing, and technological developments in molecular diagnostics, all of which improve healthcare and transfusion safety.

 

Company Profiling

Major vendors in the global blood typing market are Mesa Laboratories, Inc. (Agena Bioscience, Inc.), Danaher Corporation (Beckman Coulter), Bio-Rad Laboratories, Inc., DIAGAST, Grifols, S.A., AXO Science, Merck KGaA, Quotient, Ltd., Thermo Fisher Scientific, Immucor, Inc., BAG Diagnostics GmbH, Seegene Inc., and Others

.

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

        

Recent Development

  • In May 2024, Thermo Fisher Scientific introduced the Axiom™ BloodGenomiX™ Array, a high-throughput blood genotyping solution detecting over 260 antigens. This advancement improves donor-recipient matching, supporting safer transfusions with automated analysis. 

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global blood typing market based on the below-mentioned segments: 

 

Global Blood Typing Market, By Product & Services

  • Instruments
  • Reagents & Consumables

 

Global Blood Typing Market, ByTest

  • Antibody Screening
  • HLA Typing
  • Cross-matching

 

Global Blood Typing Market, By End User

  • Hospitals & clinics
  • Diagnostic laboratories
  • Blood banks

 

Global Blood Typing Market, Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies